Sander van Doorn1, Frans H Rutten1, G J Geersing1,2
1UMC Utrecht, Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Direct oral anticoagulants (DOACs) offer alternatives for stroke prevention in atrial fibrillation and venous thromboembolism treatment. This expert consensus compares DOACs and vitamin K antagonists, based on indirect evidence due to limited head-to-head trials.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: